title: Synthesis and binding affinities of methylvesamicol analogs for the acetylcholine transporter and sigma receptor.
abstract: We synthesized methylvesamicol analogs 13-16 and investigated the binding characteristics of 2-[4-phenylpiperidino]cyclohexanol (vesamicol) and methylvesamicol analogs 13-16, with a methyl group introduced into the 4-phenylpiperidine moiety, to sigma receptors (sigma-1, sigma-2) and to vesicular acetylcholine transporters (VAChT) in membranes of the rat brain and liver. In competitive inhibition studies, (-)-o-methylvesamicol [(-)-OMV] (13) (Ki=6.7 nM), as well as (-)-vesamicol (Ki=4.4 nM), had a high affinity for VAChT. (+)-p-Methylvesamicol [(+)-PMV] (16) (Ki=3.0 nM), as well as SA4503 (Ki=4.4 nM), reported as a sigma-1 mapping agent for positron emission tomography (PET), had a high affinity for the sigma-1 receptor. The binding affinity of (+)-PMV (16) for the sigma-1 receptor (Ki=3.0 nM) was about 13 times higher than that for the sigma-2 (sigma-2) receptor (Ki=40.7 nM). (+)-PMV (16) (Ki=199 nM) had a much lower affinity for VAChT than SA4503 (Ki=50.2 nM) and haloperidol (Ki=41.4 nM). These results showed that the binding characteristics of (-)-OMV (13) to VAChT were similar to those of (-)-vesamicol and that (+)-PMV (16) bound to the sigma-1 receptor with high affinity. In conclusion, (-)-OMV (13) and (+)-PMV (16), which had a suitable structure, with a methyl group for labeling with 11C, may become not only a new VAChT ligand and a new type of sigma receptor ligand, respectively, but may also become a new target compound of VAChT and the sigma-1 receptor radioligand for PET, respectively.
authors.affiliation: Division of Tracer Kinetics, Advanced Science Research Center, Kanazawa University, Kanazawa, Japan. shiba@med.kanazawa-u.ac.jp
authors.forename: Kazuhiro
authors.initials: K
authors.lastname: Shiba
authors.forename: Kazuma
authors.initials: K
authors.lastname: Ogawa
authors.forename: Kiichi
authors.initials: K
authors.lastname: Ishiwata
authors.forename: Kazuyoshi
authors.initials: K
authors.lastname: Yajima
authors.forename: Hirofumi
authors.initials: H
authors.lastname: Mori
mesh_terms: D000818:Animals; D001921:Brain / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D010880:Piperidines / Q000138:chemical synthesis* / Q000378:metabolism*; D011485:Protein Binding; D011869:Radioligand Assay; D051381:Rats; D017207:Rats, Sprague-Dawley; D017480:Receptors, sigma / Q000378:metabolism*; D050494:Vesicular Acetylcholine Transport Proteins / Q000378:metabolism*
chemical_list: D010880:Piperidines; D017480:Receptors, sigma; D050494:Vesicular Acetylcholine Transport Proteins; C006189:vesamicol